Investigation of carrier frequency for spinal muscular atrophy in Thailand using dried blood spot specimens
نویسندگان
چکیده
Spinal muscular atrophy (SMA) is an autosomal recessive genetic disorder, characterized by the degeneration of motor neurons of the spinal cord, thus leading to the deaths of newborns. More than 95% of SMA patients are caused by the absence of survival motor neuron 1 (SMN1) gene exon 7, located on chromosome 5q13. The SMA disease prevalence and SMA mutations in Thailand have never been reported. In this study, we aimed to explore the frequency of SMA carriers (heterozygous, loss of exon 7 in SMN1 gene) and simultaneously determine the SMN2-exon 7 copy number in Thai neonate population. We used a denaturing high-performance liquid chromatography (DHPLC)-based semiquantitative multiplex-PCR technique to detect the copy number of SMN genes by comparing with two reference genes, palmitoyl-protein thioesterase 1 and proteolipid protein 1. DNA samples were extracted from dried blood spot (DBS) specimens (n = 1,000) leftover from the Thai National Neonatal Screening Program. Results indicated that the SMA carrier frequency in the Thai newborns was 2.8% (1/36 cases). According to this data, the prevalence of SMA caused by homozygous deletion of SMN1 exon 7 in Thai newborns was estimated at 1 in 5,102 cases. In conclusion, we reported a relatively high rate of SMA carriers in Thai newborns. Additionally, the estimated incidence of SMA found in this study was comparable to that reported in other countries. Therefore, SMA could be considered as a national health problem and results from this study may be useful to establish a national program for clinical, prenatal diagnosis and genetic counseling to effectively prevent SMA in Thailand.
منابع مشابه
Newborn blood spot screening test using multiplexed real-time PCR to simultaneously screen for spinal muscular atrophy and severe combined immunodeficiency.
BACKGROUND Spinal muscular atrophy (SMA) is a motor neuron disorder caused by the absence of a functional survival of motor neuron 1, telomeric (SMN1) gene. Type I SMA, a lethal disease of infancy, accounts for the majority of cases. Newborn blood spot screening (NBS) to detect severe combined immunodeficiency (SCID) has been implemented in public health laboratories in the last 5 years. SCID d...
متن کاملAssessment of Preimplantation Genetic Diagnosis (PGD) for Childhood-onset Spinal Muscular Atrophy (SMA) Using Duplex Fluorescent PCR
متن کامل
Drawing Word co-occurrence map of Spinal Muscular Atrophy disease
Introduction: The purpose of this article is to evaluate the status of articles in the field of Spinal Muscular Atrophy According to the Scientometrics indices Word co-occurrence map of this field . Methods: The present study is an applied one with a quantitative approach and a descriptive approach. It has been done using scientometrics and the co-occurrence words analysis technique. Document...
متن کاملSpinal Muscular Atrophy: A Short Review Article
Spinal muscular atrophy (SMA) is a genetic disorder which affect nervous system and is characterized with progressive distal motor neuron weakness. The survival motor neuron (SMN) protein level reduces in patients with SMA. Two different genes code survival motor neuron protein in human genome. Skeletal and intercostal muscles denervation lead to weakness, hypotony, hyporeflexia, respiratory fa...
متن کاملSMN1 and NAIP genes deletions in different types of spinal muscular atrophy in Khuzestan province, Iran
Background: Spinal muscular atrophy (SMA) is the second most common lethal autosomal recessive disease. It is a neuromuscular disorder caused by degenerative of lower motor neurons and occasionally bulbar neurons leading to progressive limb paralysis and muscular atrophy. The SMN1 gene is recognized as a SMA causing gene while NAIP has been characterized as a modifying factor for the clinical ...
متن کامل